drugset / Trial / NCT04275024
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Adipose derived Mesenchymal Stem Cells (AD-MSCs) plus Calpocitriol Ointment and PSORI-CM01 Granule with moderate to severe psoriasis. Any adverse events related to AD-MSCs infusion will be monitored.The primary outcome is the reduction rate of PASI(Psoriasis Area and Severity Index) and treatment response will be computed from PASI before and after treatment.
Timeline
- Start
- 2020-04-01
- Primary completion
- 2020-06-17
- Completion
- 2021-02-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | adipose-derived multipotent mesenchymal stem cells | Cell therapy | 2 cells/kg | Intravenous |
| Background | Calcipotriol | Small molecule | — | Topical |
| Background | PSORI-CM01 | Unknown | 5.5 g | Oral |